Five years ago, we published an episode about the boom in home DNA testing kits, focusing on the high-flying firm 23andMe and its C.E.O. Anne Wojcicki. Their flight has been extremely bumpy since then. This update includes an additional interview with the Wall Street Journal reporter who has been investigating the firm’s collapse.
Oct 30
693. What’s Our Job as Humans Anymore?
It may just be being human. Stephen Dubner interviews A.I. performer Tilly Norwood to find out if we are as replaceable as we fear. (Part two of a two-part series.) SOURCES:Sean Astin, actor, president of SAG-AFTRA.Kevin Kelly, co-founder of Wired.Ethan Mollick, associate profess ... Show More
57m 32s
Oct 23
692. What Will A.I. Do to (and for) Human Creativity?
Writers, designers, actors, coders, musicians, thinkers — they’re all worried about being replaced by machines. But what if the A.I.s are actually here to help? (Part one of a two-part series.) SOURCES:Sean Astin, actor, president of SAG-AFTRA.Kevin Kelly, co-founder of Wired.Eth ... Show More
59m 9s
Aug 2024
How 23andMe went from a $6 billion valuation to trading for pennies
Cofounder and CEO of 23andMe, Anne Wojcicki, wants to take the public company private. Founded in 2006, the DNA-testing startup was valued at $6 billion in 2021. Now, it’s trading for less than a dollar. So what happened? ‘Fast Company’ senior writer Ainsley Harris breaks down 23 ... Show More
54m 45s
Jun 2025
23andMe's Fatal Flaw | Guess Who’s Back | 3
Just when it looked like 23andMe was selling to Regeneron Pharmaceuticals, founder Anne Wojcicki placed a bid through her new nonprofit in an attempt to win it back at the eleventh hour. Lila MacLellan, Senior Writer at Fortune, joins David to discuss Wojcicki’s leadership style, ... Show More
37m 55s